Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

Sankyo reveals potential immunosupressants

July 12, 1996

Immunosuppressive and antiinflammatory agents from Italfarmaco

July 12, 1996

Antiinflammatory bone resorption inhibitors from Takeda

July 12, 1996

Bayer discloses matrix metalloproteinase inhibitors

July 12, 1996

COX-2 inhibitors for inflammation and/or pain from Roche

July 12, 1996

Novel antibacterial agents from Pharmacia & Upjohn

July 12, 1996

Erythromycin derivatives useful for infection treatment

July 12, 1996

Lilly describes heterocyclic tachykinin antagonists

July 12, 1996

Sandoz reports new NMDA antagonist

July 5, 1996

Nippon Chemiphar reports oral hypoglycemic agents for diabetes

July 5, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...